Macrilen

Chemical Namemacimorelin acetate
Dosage FormSuspension (oral; 60 mg)
Drug ClassReceptor agonists
SystemEndocrine
CompanyNovo
Approval Year2017

Indication

  • For the diagnosis of adult growth hormone deficiency.
Last updated on 10/22/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Macrilen (macimorelin acetate) Prescribing Information 2019Novo Nordisk Inc. Plainsboro, NJ
Document TitleYearSource
Macimorelin as a diagnostic test for adult GH deficiency. 2018The Journal of Clinical Endocrinology & Metabolism